In unserem Newsroom finden Sie Aktuelles rund um die German Breast Group.
We are happy to present our work at ESMO 2021, September 16-21th
Die GBG unterstützt die Hochwasseropfer
We are delighted to inform you that our analysis on the utility of the CPS + EG score in triple-negative breast cancer patients has been published in European Journal of Cancer
We are pleased to inform you that a pooled analysis of patients with HER2-low-positive breast cancer has been published in The Lancet Oncology
A prospective analysis on chemotherapy-induced ovarian failure in young women with early breast cancer has been published in European Journal of Cancer
Made in Germany
Veranstaltungsempfehlung: 12. Klinische Pharmazie-Update-Seminar, 10. und 11. September 2021, Wiesbaden
A pooled analysis on therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer has been published in European Journal of Cancer
We are happy to inform you that results of several research projects from GBG and collaborative groups will be presented at the upcoming ASCO Annual Meeting 2021, which will take place from 4 to 8 June.
The International Immuno-Oncology Biomarker Working Group has launched a global survey on the potential use of Tumor Infiltrating Lymphocytes (TILs) for future trial designs and use in daily practice.
We are delighted to inform you that results of several research projects from GBG and collaborative groups will be presented at the upcoming ESMO Breast Cancer Virtual Meeting 2021, which will take place from 5 to 8 May 2021.
We are delighted to inform you that the first results of the randomized phase III PenelopeB trial have been published on a Rapid Communications basis in Journal of Clinical Oncology.
An analysis including breast cancer patients with brain metastases from the BMBC registry has been published in Cancers
Registration for the ESMO Breast Cancer Virtual Meeting, taking place 5-8 May 2021 is now open.
Wir danken den Referenten, Teilnehmern und Organisatoren für das tolle virtuelle Jahrestreffen. Die Präsentationen finden Sie auf unserer Website zum Download und als Video zum Nachhören.
The 17th St.Gallen International Breast Cancer Conference is going fully virtual!
A translational research project investigating genomic patterns of mutational signatures in breast cancer patients from GeparSepto trial has been published in Annals of Oncology.
We are delighted to inform you that final results of the first randomized phase II MALE trial have been published in JAMA Oncology.
IDMC has concluded that OlympiA trial crossed superiority boundary for invasive disease-free survival vs. placebo at planned interim analysis. OlympiA Phase III trial of Lynparza in the adjuvant treatment of BRCA-mutated HER2-negative high-risk early breast cancer will be analysed and reported early.
GBG Jahrestreffen vom 24. bis 26. Februar 2021 wissenschaftliche Veranstaltung